CY1106086T1 - Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα - Google Patents

Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα

Info

Publication number
CY1106086T1
CY1106086T1 CY20061100500T CY061100500T CY1106086T1 CY 1106086 T1 CY1106086 T1 CY 1106086T1 CY 20061100500 T CY20061100500 T CY 20061100500T CY 061100500 T CY061100500 T CY 061100500T CY 1106086 T1 CY1106086 T1 CY 1106086T1
Authority
CY
Cyprus
Prior art keywords
methylon
androgens
beta
substituted
preparation
Prior art date
Application number
CY20061100500T
Other languages
English (en)
Inventor
Dirk Leysen
Jaap Van Der Louw
Roberta Buma Bursi
Marcel Evert De Gooyer
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of CY1106086T1 publication Critical patent/CY1106086T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)

Abstract

Η εφεύρεση που αποκαλύπτεται σχετίζεται με το αναπάντεχο εύρημα νέων στεροειδών τα οποία χαρακτηρίζονται από ένα 14β,15β-κυκλοπροπανικό δακτύλιο και μια 17α υδροξυμεθυλική ομάδα. Αυτά τα στεροειδή σύμφωνα με την εφεύρεση βρέθηκαν να έχουν κοινό μια ανδρογόνο δράση. Μπορούν να χρησιμοποιούνται για την παρασκευή μιας ουσίας για ανδρική αντισύλληψη, καθώς επίσης για την παρασκευή ενός φαρμάκου για τη θεραπεία της ανεπάρκειας ανδρογόνου.
CY20061100500T 1999-12-02 2006-04-10 Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα CY1106086T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99204080 1999-12-02
PCT/EP2000/012009 WO2001040255A2 (en) 1999-12-02 2000-11-29 14,15-beta-methylene substituted androgens
EP00993259A EP1237904B1 (en) 1999-12-02 2000-11-29 14,15-beta-methylene substituted androgens

Publications (1)

Publication Number Publication Date
CY1106086T1 true CY1106086T1 (el) 2011-06-08

Family

ID=8240955

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100500T CY1106086T1 (el) 1999-12-02 2006-04-10 Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα

Country Status (27)

Country Link
US (1) US6706700B2 (el)
EP (1) EP1237904B1 (el)
JP (1) JP2003515543A (el)
CN (1) CN1166680C (el)
AR (1) AR026655A1 (el)
AT (1) ATE317396T1 (el)
AU (1) AU778017B2 (el)
CA (1) CA2390226A1 (el)
CO (1) CO5251441A1 (el)
CY (1) CY1106086T1 (el)
CZ (1) CZ301376B6 (el)
DE (1) DE60025958T2 (el)
DK (1) DK1237904T3 (el)
ES (1) ES2258037T3 (el)
HK (1) HK1047596B (el)
HU (1) HUP0203611A3 (el)
IL (1) IL149424A (el)
MX (1) MXPA02004939A (el)
NO (1) NO322422B1 (el)
NZ (1) NZ518753A (el)
PE (1) PE20011033A1 (el)
PL (1) PL202999B1 (el)
RU (1) RU2242479C2 (el)
SK (1) SK287095B6 (el)
TW (1) TWI275593B (el)
WO (1) WO2001040255A2 (el)
ZA (1) ZA200203536B (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60004377T2 (de) * 1999-04-06 2004-06-09 Akzo Nobel N.V. Oral wirksame 7-alpha-alkyl androgene
MXPA04007049A (es) * 2002-01-21 2004-10-14 Akzo Nobel Nv Proceso para la preparacion de 7a-metilesteroides.
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
DK2764008T3 (en) * 2011-10-07 2016-11-07 Estetra Sprl A process for the preparation of estetrol
ES2877186T3 (es) 2015-06-18 2021-11-16 Estetra Sprl Comprimido orodispersable que contiene estetrol
GEP20217243B (en) 2015-06-18 2021-04-26 Sprl Estetra Orodispersible dosage unit containing an estetrol component
LT3310346T (lt) 2015-06-18 2021-06-10 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
TN2017000499A1 (en) 2015-06-18 2019-04-12 Mithra Pharmaceuticals S A Orodispersible dosage unit containing an estetrol component
KR20220144885A (ko) 2016-08-05 2022-10-27 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
CN111621141B (zh) * 2020-06-12 2022-04-08 广西大学 一种缓释型二氧化氯-水性聚氨酯抗菌膜及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3086027A (en) 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
DE19537626A1 (de) 1995-10-10 1997-04-17 Jenapharm Gmbh Steroide mit einer 14, 15-Methylengruppe
DE19827522A1 (de) * 1998-06-22 1999-12-23 Jenapharm Gmbh 14,15-Cyclopropanosteroide der 19-Nor-Androstanreihe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
CA2359218A1 (en) 1999-03-08 2000-09-14 Akzo Nobel N.V. 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens

Also Published As

Publication number Publication date
SK287095B6 (sk) 2009-12-07
DK1237904T3 (da) 2006-06-06
CZ301376B6 (cs) 2010-02-03
CA2390226A1 (en) 2001-06-07
CZ20021894A3 (cs) 2002-08-14
PL202999B1 (pl) 2009-08-31
PL355689A1 (en) 2004-05-17
WO2001040255A3 (en) 2001-11-15
NO322422B1 (no) 2006-10-02
CO5251441A1 (es) 2003-02-28
HUP0203611A3 (en) 2004-07-28
MXPA02004939A (es) 2003-05-23
AR026655A1 (es) 2003-02-19
CN1166680C (zh) 2004-09-15
PE20011033A1 (es) 2001-10-11
TWI275593B (en) 2007-03-11
EP1237904A2 (en) 2002-09-11
HK1047596A1 (en) 2003-02-28
NO20022564L (no) 2002-05-30
ES2258037T3 (es) 2006-08-16
AU2838301A (en) 2001-06-12
DE60025958D1 (de) 2006-04-20
SK7582002A3 (en) 2002-09-10
AU778017B2 (en) 2004-11-11
ZA200203536B (en) 2003-08-04
DE60025958T2 (de) 2006-07-27
JP2003515543A (ja) 2003-05-07
IL149424A (en) 2007-05-15
EP1237904B1 (en) 2006-02-08
IL149424A0 (en) 2002-11-10
NZ518753A (en) 2004-05-28
HK1047596B (zh) 2006-04-21
HUP0203611A2 (hu) 2003-03-28
CN1402735A (zh) 2003-03-12
ATE317396T1 (de) 2006-02-15
WO2001040255A2 (en) 2001-06-07
US6706700B2 (en) 2004-03-16
NO20022564D0 (no) 2002-05-30
RU2242479C2 (ru) 2004-12-20
US20030100543A1 (en) 2003-05-29

Similar Documents

Publication Publication Date Title
CY1106086T1 (el) Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα
ES2174629T3 (es) 14,15-ciclopropano-esteroides de la serie de los 19-nor-androstanos, procedimiento para su preparacion y formulaciones farmaceuticas que contienen estos compuestos.
CY1109404T1 (el) Μεθοδος δια την παρασκευη προϊοντων στεροειδους ορμονης. η οποια περιλαμβανει παραγοντα σταθεροποιησεως εις μη-κρυσταλλικην μορφη
ZA200107631B (en) Indoline derivatives as progesterone antagonists.
CY1105065T1 (el) Φαρμακευτικα μεσα βασιζομενα σε γεσταγονα για δepματικη χρηση
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
MY122411A (en) Controlled release galantamine composition
CY1106463T1 (el) Τοπικη ορμονικη συνθεση με συστημικο αποτελεσμα
TR199800648A1 (xx) �ki veya daha fazla etken madde i�in ila� verme sistemi.
TR200101826T2 (tr) Üç-fazlı ağızdan alınan gebelik önleyici ilaç
HUP9901144A2 (hu) Hatóanyagként klopidogrel és egy antitrombotikum új kombinációját tartalmazó gyógyszerkészítmények
NO965516D0 (no) Sterolderivater anvendt til regulering av meiose
NO985232D0 (no) Androstenderivater
ATE452641T1 (de) Orale pharmazeutische zusammensetzung enthaltend 15-hydroxytestosteron und seine derivate
ATE215817T1 (de) Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
MXPA01011606A (es) Terapia anti-inflamatoria para infeccion mediada por inflamacion.
ATE225800T1 (de) Nichtestrogene derivate des estradiols mit antioxidativer aktivität
IL139861A (en) 17beta-AMINO-AND HYDROXYLAMINO -11 beta - ARYLSTEROID DERIVATIVES, METHODS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
ATE160573T1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
AR022852A1 (es) Nuevos androgenos
TR199802496T2 (xx) Konjestif kalp yetmezli�ini tedavi i�in form�lasyon.
EE05186B1 (et) 4-halogeenitud-17-metleensteroidid, nende valmistamismeetod ja neid hendeid sisaldavad farmatseutilised kompositsioonid
BR0016092A (pt) Composto, uso de um composto kit para contracepção hormonal em um macho, e, método de tratamento
CY1116481T1 (el) Φαρμακοτεχνικη μορφη περιεχουσα παραγωγα φωσφορικου των παραγοντων μεταφορας ηλεκτρονιου
ECSP003379A (es) Nuevos esteroides